Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Postoperative Pain in Total Knee Arthroplasty
NCT03303794Phase 3Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bupivacaine in postoperative pain, sponsored by Montefiore Medical Center. Primary endpoint: Activity Measure for Post-Acute Care. Started Oct 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03303794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303794.